Acurx Pharmaceuticals Inc...

NASDAQ: ACXP · Real-Time Price · USD
5.11
0.25 (5.14%)
At close: Aug 15, 2025, 3:59 PM
5.12
0.20%
After-hours: Aug 15, 2025, 05:58 PM EDT

Acurx Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-14.1M -14.58M -12.09M -12.75M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
3.44M 3.77M 3.3M 6.74M
Other Working Capital
206.06K 1.14M 30.35K 141.28K
Other Non-Cash Items
-89 227.00 1K 850.72K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
284.09K 1.01M 1.25M 141.28K
Operating Cash Flow
-10.38M -9.8M -7.54M -5.01M
Capital Expenditures
n/a 5.00 n/a -3
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -5 n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
210K 2.22M n/a n/a
Financial Cash Flow
6.62M 8.16M 3.69M 14.8M
Net Cash Flow
-3.77M -1.64M -3.85M 9.78M
Free Cash Flow
-10.38M -9.8M -7.54M -5.01M